Movano Health, Inc. (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.
Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality. The ring communicates wirelessly with a companion mobile application, where users can view detailed daily reports, set personalized health goals, and share data securely with healthcare providers or loved ones. By combining hardware design with cloud-based analytics, Movano aims to deliver actionable insights that support preventive care and early intervention.
To advance its platform, Movano collaborates with academic institutions, clinical researchers and technology partners. These collaborations help validate sensor accuracy, refine algorithms and explore new applications in areas such as women’s health, chronic disease management and fitness optimization. The company’s development roadmap includes pursuing regulatory clearances and expanding integrations with electronic health record systems.
Led by a management team with combined expertise in medical devices, consumer electronics and software development, Movano serves customers primarily in North America and is exploring opportunities for expansion into international markets. The company continues to invest in research and development to enhance its sensor suite and broaden its suite of health-monitoring solutions for both consumers and healthcare professionals.
AI Generated. May Contain Errors.
